VIVO - Meridian Bioscience, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5419.43M
Enterprise Value 3451.16M
Trailing P/E 16.37
Forward P/E 119.25
PEG Ratio (5 yr expected) 10.92
Price/Sales (ttm)2.06
Price/Book (mrq)2.22
Enterprise Value/Revenue 32.22
Enterprise Value/EBITDA 68.73

Trading Information

Stock Price History

Beta (3Y Monthly) 0.13
52-Week Change 3-35.80%
S&P500 52-Week Change 31.35%
52 Week High 319.84
52 Week Low 39.70
50-Day Moving Average 311.30
200-Day Moving Average 313.19

Share Statistics

Avg Vol (3 month) 3303.4k
Avg Vol (10 day) 3218.93k
Shares Outstanding 542.63M
Float 39.17M
% Held by Insiders 11.10%
% Held by Institutions 195.01%
Shares Short (Jul 31, 2019) 42.78M
Short Ratio (Jul 31, 2019) 410.07
Short % of Float (Jul 31, 2019) 49.96%
Short % of Shares Outstanding (Jul 31, 2019) 46.51%
Shares Short (prior month Jun 28, 2019) 42.73M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.25
Trailing Annual Dividend Yield 32.48%
5 Year Average Dividend Yield 44.03
Payout Ratio 462.50%
Dividend Date 3Feb 14, 2019
Ex-Dividend Date 4Feb 1, 2019
Last Split Factor (new per old) 22/3
Last Split Date 3May 14, 2007

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 12.65%
Operating Margin (ttm)21.18%

Management Effectiveness

Return on Assets (ttm)9.34%
Return on Equity (ttm)14.14%

Income Statement

Revenue (ttm)203.27M
Revenue Per Share (ttm)4.78
Quarterly Revenue Growth (yoy)-6.40%
Gross Profit (ttm)130.46M
Net Income Avi to Common (ttm)25.71M
Diluted EPS (ttm)0.60
Quarterly Earnings Growth (yoy)-25.60%

Balance Sheet

Total Cash (mrq)55.19M
Total Cash Per Share (mrq)1.29
Total Debt (mrq)75.82M
Total Debt/Equity (mrq)40.21
Current Ratio (mrq)6.93
Book Value Per Share (mrq)4.42

Cash Flow Statement

Operating Cash Flow (ttm)39.55M
Levered Free Cash Flow (ttm)34.19M